Said Antonio Durante Furnieles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Said Antonio Durante Furnieles has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Héctor Andrés Guerra Romero
Universidad Surcolombiana
3 shared publications - Andrés Arturo Vivas Chacon
Universidad de La Sabana
2 shared publications - Angie Tatiana Valero Palomino
Hospital Universitario Hernando Moncaleano Perdomo
1 shared publication - Claudia Patricia Salas Navarro
Universidad Metropolitana
1 shared publication - Elina del Amparo Ortega Trocha
Clínica Blas de Lezo y/ o clínica de la mujer. Colombia
1 shared publication - Fabio Luis Julio Suárez
Corporación Universitaria Remington
1 shared publication
Latest Publications
- 1 February 2026
- Published by Revista Sanitaria de Investigación in Revista sanitaria de investigación
- Vol. VII (02)
ACTUALIZACIÓN EXHAUSTIVA EN EL ABORDAJE DE LA COJERA EN LA POBLACIÓN PEDIÁTRICA.FISIOPATOLOGÍA, DIAGNÓSTICO DIFERENCIAL Y CONTROVERSIAS TERAPÉUTICAS CONTEMPORÁNEAS.
Introducción: La cojera aguda en la población pediátrica constituye un motivo de consulta frecuente, representando entre el 0.6% y el 0.7% de las visitas a urgencias. El diagnóstico diferencial es amplio y depende de la edad. Objetivo: Analizar la literatura reciente (2020-2025) para identificar cambios en el perfil microbiológico, la validez de los criterios diagnósticos clásicos y las nuevas estrategias terapéuticas en patología de cadera y trauma menor. Metodología: Se realizó una revisión sistemática en las bases de datos PubMed, Cochrane y Google Scholar. Se seleccionaron artículos en inglés y español, priorizando ensayos clínicos, metaanálisis y guías de práctica clínica que abordaran Kingella kingae, fracturas ocultas y deslizamiento epifisario. Resultados: Se identificó que Kingella kingae es la causa principal de artritis en menores de 4 años, presentando una clínica silente que evade los criterios de Kocher. En trauma, la inmovilización con bota extraíble mostró no inferioridad frente al yeso. En el deslizamiento epifisario, la evidencia favorece la fijación profiláctica contralateral. Discusión-Conclusiones: Los protocolos diagnósticos deben priorizar pruebas moleculares sobre reactantes de fase aguda en preescolares. La resonancia magnética es superior a la ecografía en casos dudosos. Las tendencias terapéuticas actuales tienden a ser menos invasivas en trauma y más preventivas en patología de cadera.
- 1 February 2026
- Published by Revista Sanitaria de Investigación in Revista sanitaria de investigación
- Vol. VII (02)
ACTUALIZACIÓN EXHAUSTIVA EN EL ABORDAJE DE LA COJERA EN LA POBLACIÓN PEDIÁTRICA.FISIOPATOLOGÍA, DIAGNÓSTICO DIFERENCIAL Y CONTROVERSIAS TERAPÉUTICAS CONTEMPORÁNEAS.
Introducción: La cojera aguda en la población pediátrica constituye un motivo de consulta frecuente, representando entre el 0.6% y el 0.7% de las visitas a urgencias. El diagnóstico diferencial es amplio y depende de la edad. Objetivo: Analizar la literatura reciente (2020-2025) para identificar cambios en el perfil microbiológico, la validez de los criterios diagnósticos clásicos y las nuevas estrategias terapéuticas en patología de cadera y trauma menor. Metodología: Se realizó una revisión sistemática en las bases de datos PubMed, Cochrane y Google Scholar. Se seleccionaron artículos en inglés y español, priorizando ensayos clínicos, metaanálisis y guías de práctica clínica que abordaran Kingella kingae, fracturas ocultas y deslizamiento epifisario. Resultados: Se identificó que Kingella kingae es la causa principal de artritis en menores de 4 años, presentando una clínica silente que evade los criterios de Kocher. En trauma, la inmovilización con bota extraíble mostró no inferioridad frente al yeso. En el deslizamiento epifisario, la evidencia favorece la fijación profiláctica contralateral. Discusión-Conclusiones: Los protocolos diagnósticos deben priorizar pruebas moleculares sobre reactantes de fase aguda en preescolares. La resonancia magnética es superior a la ecografía en casos dudosos. Las tendencias terapéuticas actuales tienden a ser menos invasivas en trauma y más preventivas en patología de cadera.
- Open Access
- 16 January 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 1646-1656
Transformación Epistemológica y Manejo de Precisión en Neuro-Otología: Una Revisión Sistemática de la Literatura (2020-2025)
Objective: To analyze the transformation of diagnostic and therapeutic paradigms in the management of vertigo and vestibular disorders, evaluating recent evidence on emergency clinical algorithms, pharmacological safety in vulnerable populations, and the emergence of precision medicine in inner ear pathologies. Method: A systematic literature review was conducted following PRISMA methodology. Biomedical databases (PubMed, Cochrane Library, Embase) and clinical trial registries were consulted to identify studies published between January 2020 and February 2025. Meta-analyses, randomized controlled trials, and clinical practice guidelines (Bárány Society, ACORL, IETS) were included. Results: Current evidence dismisses diagnosis based on symptom quality ("vertigo" vs. "dizziness") in favor of the TiTrATE model (Timing, Triggers, And Targeted Examination). HINTS+ and STANDING physical examination protocols demonstrate superior sensitivity to diffusion-weighted magnetic resonance imaging (DWI) in the first 48 hours of acute vestibular syndrome (AVS). In pharmacology, the 2024 Beers Criteria severely restrict the use of vestibular antihistamines in geriatrics, while droperidol re-emerges as a safe antiemetic standard at low doses. In Menière's Disease, the identification of immunological phenotypes and rare genetic variants paves the way for targeted therapies such as Ebselen (SPI-1005). Regarding vestibular neuritis, recent meta-analyses (2024-2025) confirm the inefficacy of corticosteroids for long-term functional recovery. Conclusions: Neuro-otology is transitioning towards a stage of diagnostic precision where instrumented oculomotor semiology and molecular biomarkers displace indiscriminate imaging and empirical vestibular suppression. Urgent updating of hospital protocols is required to integrate these findings and minimize iatrogenesis in at-risk populations.
- 16 January 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 1646-1656
Open AccessTransformación Epistemológica y Manejo de Precisión en Neuro-Otología: Una Revisión Sistemática de la Literatura (2020-2025)
Objective: To analyze the transformation of diagnostic and therapeutic paradigms in the management of vertigo and vestibular disorders, evaluating recent evidence on emergency clinical algorithms, pharmacological safety in vulnerable populations, and the emergence of precision medicine in inner ear pathologies. Method: A systematic literature review was conducted following PRISMA methodology. Biomedical databases (PubMed, Cochrane Library, Embase) and clinical trial registries were consulted to identify studies published between January 2020 and February 2025. Meta-analyses, randomized controlled trials, and clinical practice guidelines (Bárány Society, ACORL, IETS) were included. Results: Current evidence dismisses diagnosis based on symptom quality ("vertigo" vs. "dizziness") in favor of the TiTrATE model (Timing, Triggers, And Targeted Examination). HINTS+ and STANDING physical examination protocols demonstrate superior sensitivity to diffusion-weighted magnetic resonance imaging (DWI) in the first 48 hours of acute vestibular syndrome (AVS). In pharmacology, the 2024 Beers Criteria severely restrict the use of vestibular antihistamines in geriatrics, while droperidol re-emerges as a safe antiemetic standard at low doses. In Menière's Disease, the identification of immunological phenotypes and rare genetic variants paves the way for targeted therapies such as Ebselen (SPI-1005). Regarding vestibular neuritis, recent meta-analyses (2024-2025) confirm the inefficacy of corticosteroids for long-term functional recovery. Conclusions: Neuro-otology is transitioning towards a stage of diagnostic precision where instrumented oculomotor semiology and molecular biomarkers displace indiscriminate imaging and empirical vestibular suppression. Urgent updating of hospital protocols is required to integrate these findings and minimize iatrogenesis in at-risk populations.
- Open Access
- 16 January 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 997-1003
La Neumonía en la era de la Precisión: Integrando la Evidencia 2025 con la Realidad Epidemiológica Colombiana
Introduction: Community-acquired pneumonia (CAP) is no longer a static clinical entity but rather a dynamic syndrome of systemic dysregulation. The publication of the 2025 American Thoracic Society (ATS) guidelines and the recommendations of the Colombian Association of Infectious Diseases (ACIN) demand a profound update of clinical practice. Development: Through a narrative review of the 2024–2025 literature, this article proposes a paradigm shift from blind empirical treatment to phenotype-driven therapy guided by local ecology. Colombian epidemiology is analyzed, highlighting macrolide resistance in Streptococcus pneumoniae (>30%), which mandates abandonment of monotherapy. Risk stratification is discussed, demonstrating the superiority of the SMART-COP score over CURB-65 in predicting the need for intensive respiratory or vasopressor support. From a therapeutic standpoint, the use of hydrocortisone in severe CAP is validated (CAPE COD trial), and ampicillin/sulbactam is positioned as the cornerstone of local inpatient management, with emphasis on safety protocols to prevent cefepime-associated neurotoxicity. Conclusion: Precision medicine in pneumonia is not a luxury but a safety standard. Adapting global evidence to local microbiology and using advanced predictive scores are life-saving interventions.
- 16 January 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 997-1003
Open AccessLa Neumonía en la era de la Precisión: Integrando la Evidencia 2025 con la Realidad Epidemiológica Colombiana
Introduction: Community-acquired pneumonia (CAP) is no longer a static clinical entity but rather a dynamic syndrome of systemic dysregulation. The publication of the 2025 American Thoracic Society (ATS) guidelines and the recommendations of the Colombian Association of Infectious Diseases (ACIN) demand a profound update of clinical practice. Development: Through a narrative review of the 2024–2025 literature, this article proposes a paradigm shift from blind empirical treatment to phenotype-driven therapy guided by local ecology. Colombian epidemiology is analyzed, highlighting macrolide resistance in Streptococcus pneumoniae (>30%), which mandates abandonment of monotherapy. Risk stratification is discussed, demonstrating the superiority of the SMART-COP score over CURB-65 in predicting the need for intensive respiratory or vasopressor support. From a therapeutic standpoint, the use of hydrocortisone in severe CAP is validated (CAPE COD trial), and ampicillin/sulbactam is positioned as the cornerstone of local inpatient management, with emphasis on safety protocols to prevent cefepime-associated neurotoxicity. Conclusion: Precision medicine in pneumonia is not a luxury but a safety standard. Adapting global evidence to local microbiology and using advanced predictive scores are life-saving interventions.
- Open Access
- 16 January 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 409-416
La Precisión Glucocorticoidea en la era de la Medicina Personalizada: Una Revisión Sistemática y Consenso Multidisciplinario Sobre Farmacodinamia, Optimización de Dosis y Estrategias de Seguridad (2025)
More than seventy years after their discovery, the administration of systemic glucocorticoids remains one of the most ubiquitous and decisive interventions in both hospital and outpatient medicine. However, their use has historically been governed by empirical paradigms that prioritized absolute immunosuppression over metabolic preservation. In 2025, a doctrinal shift grounded in molecular biology is underway, marked by the recognition of a “genomic efficacy ceiling” and the dissociation between therapeutic and toxic effects. This comprehensive review synthesizes current evidence derived from pivotal trials such as PEXIVAS and from clinical guidelines issued by KDIGO, ACR, and EULAR (2024), in order to propose a new standard of care. The pharmacological futility of massive oral doses due to receptor saturation is discussed, pulse therapy is redefined toward reduced-dose regimens to minimize infectious risk, and precise endocrinological algorithms are established for the management of the hypothalamic–pituitary–adrenal axis during drug withdrawal. Finally, the mandatory implementation of a prophylactic “safety package” is proposed as an unavoidable ethical requirement in contemporary prescribing practice.
- 16 January 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (1) , 409-416
Open AccessLa Precisión Glucocorticoidea en la era de la Medicina Personalizada: Una Revisión Sistemática y Consenso Multidisciplinario Sobre Farmacodinamia, Optimización de Dosis y Estrategias de Seguridad (2025)
More than seventy years after their discovery, the administration of systemic glucocorticoids remains one of the most ubiquitous and decisive interventions in both hospital and outpatient medicine. However, their use has historically been governed by empirical paradigms that prioritized absolute immunosuppression over metabolic preservation. In 2025, a doctrinal shift grounded in molecular biology is underway, marked by the recognition of a “genomic efficacy ceiling” and the dissociation between therapeutic and toxic effects. This comprehensive review synthesizes current evidence derived from pivotal trials such as PEXIVAS and from clinical guidelines issued by KDIGO, ACR, and EULAR (2024), in order to propose a new standard of care. The pharmacological futility of massive oral doses due to receptor saturation is discussed, pulse therapy is redefined toward reduced-dose regimens to minimize infectious risk, and precise endocrinological algorithms are established for the management of the hypothalamic–pituitary–adrenal axis during drug withdrawal. Finally, the mandatory implementation of a prophylactic “safety package” is proposed as an unavoidable ethical requirement in contemporary prescribing practice.